Stock Market Today: S&P 500, Nasdaq 100 Futures Rise as US-Iran Exchange Strikes—Levi Strauss, AZZ, Ionis
U.S. stock index futures rose after a mixed prior session, amid renewed U.S.-Iran tensions and Treasury yields at 4.56% (10-year) and 4.19% (2-year). CME FedWatch showed a 72.7% chance the Fed holds rates in July. Company moves: LEVI fell premarket despite Q2 results and FY2026 guidance; AZZ rose on record sales and FY2027 guidance; IONS dropped after a Phase 3 missed endpoint; WDFC was flat ahead of earnings.
How this was made
The 30-second read
Why it matters
Near-term trading is most actionable for the named single stocks with same-day catalysts (AZZ guidance and sales, IONS Phase 3 miss) and for WD-40’s after-close earnings expectations. Macro context (rates and geopolitical risk) can amplify index-level volatility but is not a direct new fundamental datapoint for the individual companies.
Market read
Index futures are up, but the tradable edge is in single-name catalysts: AZZ’s guidance-driven surge and IONS’s Phase 3 failure are likely to dominate relative performance.
What to watch
The article does not provide consensus comparisons for the guidance changes, so traders may be reacting to expectation gaps rather than the absolute guidance numbers.
Background
The piece is a US futures and market wrap that also highlights several company-specific premarket moves and an upcoming earnings date, alongside FedWatch rate probabilities and Iran-related comments.
Ticker impact
Levi Strauss shares fell 6.07% premarket despite better-than-expected Q2 earnings and a FY2026 guidance raise.
Near-term volatility likely as traders reassess what drove the premarket selloff versus the guidance increase.
The article provides the direction and magnitude of the premarket move plus the fact of raised guidance, implying a mismatch that can drive continued trading activity.
Honeywell was slightly lower after raising FY26 adjusted earnings guidance following a 1-for-2 reverse stock split.
Limited follow-through expected unless traders interpret the guidance raise as materially different from expectations.
The move is only -0.03% and the article does not quantify the guidance change versus consensus, limiting conviction.
AZZ jumped 8.35% after reporting record quarterly sales in both segments and raising fiscal 2027 guidance.
Momentum bias likely into the next sessions as traders price in the raised fiscal 2027 outlook.
The article ties the same-day surge directly to record sales and raised guidance, which is typically actionable for near-term positioning.
Ionis shares slipped 13.76% as its Phase 3 CARDIO-TTRansform trial missed its primary endpoint.
Further downside risk likely as investors reprice probability of success and future development timelines.
A Phase 3 primary endpoint miss is a decisive binary event, and the article provides the magnitude of the immediate selloff.
WD-40 was unchanged as analysts expect earnings of $1.56 per share on $172.79M revenue after the close.
Post-close reaction risk is elevated; direction depends on whether results beat or miss the stated expectations.
The article does not state an actual earnings release or surprise, only what analysts expect.
Market effects
Rate expectations and geopolitical risk can swing defensives and cyclicals, while AI speculation is cited as driving violent sector rotations.
Asian markets were mixed, which may affect open-through sentiment for US futures.
Iran-US Strait of Hormuz rhetoric can influence energy risk premia, feeding into broader global risk appetite.
Counterpoint
The futures rise may be more about macro positioning than company fundamentals, so single-name reactions (especially LEVI and IONS) could be overextended intraday.
Key entities
- equityLevi Strauss & Co.
Pre-market shares fell 6.07% despite better-than-expected Q2 earnings and raised FY2026 guidance.
- equityAZZ Inc.
Shares rose 8.35% on record quarterly sales in both segments and raised fiscal 2027 guidance.
- equityIonis Pharmaceuticals Inc.
Shares fell 13.76% after its Phase 3 CARDIO-TTRansform trial missed the primary endpoint.
- equityHoneywell International Inc.
Shares were down 0.03% after raising FY26 adjusted earnings guidance following a 1-for-2 reverse split.
- equityWD-40 Co.
Unchanged premarket ahead of an after-close earnings report expected at $1.56 EPS and $172.79M revenue.
